170 related articles for article (PubMed ID: 7796124)
21. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site.
Peeters BW; Vanderheyden PM
Epilepsy Res; 1992 Jul; 12(2):157-62. PubMed ID: 1356759
[TBL] [Abstract][Full Text] [Related]
23. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
24. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment.
Nowak G; Li Y; Paul IA
Eur J Pharmacol; 1996 Jan; 295(1):75-85. PubMed ID: 8925878
[TBL] [Abstract][Full Text] [Related]
25. NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides.
Holemans S; De Paermentier F; Horton RW; Crompton MR; Katona CL; Maloteaux JM
Brain Res; 1993 Jul; 616(1-2):138-43. PubMed ID: 8358605
[TBL] [Abstract][Full Text] [Related]
26. Allosteric interactions and modulator requirement for NMDA receptor function.
Marvizón JC; Baudry M
Eur J Pharmacol; 1994 Oct; 269(2):165-75. PubMed ID: 7531646
[TBL] [Abstract][Full Text] [Related]
27. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
Oblin A; Schoemaker H
Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
[TBL] [Abstract][Full Text] [Related]
28. Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims.
Nowak G; Szewczyk B; Sadlik K; Piekoszewski W; Trela F; Florek E; Pilc A
Pol J Pharmacol; 2003; 55(3):455-9. PubMed ID: 14506326
[TBL] [Abstract][Full Text] [Related]
29. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
[TBL] [Abstract][Full Text] [Related]
30. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain.
McCabe RT; Sofia RD; Layer RT; Leiner KA; Faull RL; Narang N; Wamsley JK
J Pharmacol Exp Ther; 1998 Aug; 286(2):991-9. PubMed ID: 9694960
[TBL] [Abstract][Full Text] [Related]
31. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
Danysz W; Fadda E; Wroblewski JT; Costa E
Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
[TBL] [Abstract][Full Text] [Related]
32. Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex: alterations by ethanol in vitro and by chronic in vivo ethanol ingestion.
Snell LD; Tabakoff B; Hoffman PL
Brain Res; 1993 Jan; 602(1):91-8. PubMed ID: 8448662
[TBL] [Abstract][Full Text] [Related]
33. Putative NMDA receptors in Hydra: a biochemical and functional study.
Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
[TBL] [Abstract][Full Text] [Related]
34. Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation.
Sircar R; Zukin SR
Brain Res; 1991 Aug; 556(2):280-4. PubMed ID: 1682009
[TBL] [Abstract][Full Text] [Related]
35. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
[TBL] [Abstract][Full Text] [Related]
36. Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
Mugnaini M; Meoni P; Bunnemann B; Corsi M; Bowery NG
Br J Pharmacol; 2001 Apr; 132(8):1883-97. PubMed ID: 11309261
[TBL] [Abstract][Full Text] [Related]
37. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
[TBL] [Abstract][Full Text] [Related]
38. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
Standley CA
Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
[TBL] [Abstract][Full Text] [Related]
39. Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex.
Nowak G
Pol J Pharmacol; 1996; 48(2):137-43. PubMed ID: 9112643
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of [3H]-(+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis.
Tacconi S; Ratti E; Marien MR; Gaviraghi G; Bowery NG
Br J Pharmacol; 1993 Mar; 108(3):577-82. PubMed ID: 8096780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
